Unicycive Therapeutics, Inc.
NASDAQ:UNCYBiotechnology
-$0.24 today
- Market cap
- $104.19M
- Beta
- 1.73
- P/E (TTM)
- -40.8
- EPS (TTM)
- -$0.17
Volume 1.39M
Average 0.65M
UNCY Other Non-current Assets
Long-term assets not reported separately.
Unicycive Therapeutics, Inc.NASDAQ: UNCY
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets remains negative
Q1 FY2026 other non-current assets was $0, compared with $0 a year earlier.
Context
- Other non-current assets amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other non-current assets increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Non-current Assets vs competitors
How UNCY compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Other non-current assets amounts to 0.0% of total assets for UNCY, versus a peer median of 0.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $25.73M USD | -57.8% | +93.3% | 14.3% | |
ACRVAcrivon Therapeutics, Inc. Common Stock | Mar 2026 | $1.7M USD | -7.6% | +68.5% | 1.6% |
| Mar 2026 | $970K USD | -40.3% | — | 0.9% | |
CBUSCibus, Inc. | Mar 2026 | $824K USD | -27.5% | — | 0.3% |
| Mar 2026 | $296K USD | +24.9% | -1.7% | 0.3% | |
| Mar 2026 | $19.5K USD | -11.3% | -17.6% | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
HYFTMindWalk Holdings Corp. | Jan 2026 | CA$0 CAD | -100.0% | -24.9% | 0.0% |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Peer median (excluding UNCY) | — | -33.9% | -1.7% | 0.3% | |
Competitors are the stored peer set for UNCY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Unicycive Therapeutics, Inc.
NASDAQ:UNCY
Intrinsic Alpha fair value
Locked
Current Price
$3.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.